BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/14/2023 5:08:46 AM | Browse: 63 | Download: 49
 |
Received |
|
2023-08-12 07:32 |
|
Peer-Review Started |
|
2023-08-12 07:35 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-09-12 16:32 |
|
Revised |
|
2023-09-25 16:02 |
|
Second Decision |
|
2023-10-11 23:51 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2023-10-16 08:22 |
|
Articles in Press |
|
2023-10-16 08:22 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2023-10-23 21:12 |
|
Typeset the Manuscript |
|
2023-12-06 09:38 |
|
Publish the Manuscript Online |
|
2023-12-14 05:08 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Prognostic value of T cell immunoglobulin and mucin-domain containing-3 expression in upper gastrointestinal tract tumors: A meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jing-Jing Yan, Bing-Bing Liu, Yan Yang, Meng-Ru Liu, Han Wang, Zhen-Quan Deng and Zhi-Wei Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the Science and Technology Research Project of Colleges and Universities of Hebei Province |
QN2020234 |
| the Precision Medicine Joint Cultivation Fund Project of Natural Science Foundation of Hebei Province |
H2021402007 |
| the Clinical Medicine Talent Cultivation Project of Health Commission of Hebei Province |
2020 |
| the Medical Science Research Project of Health Commission of Hebei Province |
20211392 |
|
| Corresponding Author |
Zhi-Wei Zhang, MD, PhD, Attending Doctor, Department of Oncology, Affiliated Hospital of Hebei University of Engineering, No. 81 Congtai Road, Congtai District, Handan 056000, Hebei Province, China. zhangzw128@126.com |
| Key Words |
Immune checkpoint; T cell immunoglobulin-3; Gastric cancer; Overall survival; Clinicopathological features |
| Core Tip |
Immune checkpoint receptor inhibitors have changed history in the long history of treating tumors, and T cell immunoglobulin and mucin-domain containing-3 (TIM3) is one of these immune checkpoint receptors. The study initially evaluated the survival-prognostic effect of TIM3 in upper gastrointestinal tumors by conducting a meta-analysis, aggregating data from several independent studies, and providing the latest comprehensive insights into the field, and further advances in immunotherapy, hoping to provide some value to future research. |
| Publish Date |
2023-12-14 05:08 |
| Citation |
Yan JJ, Liu BB, Yang Y, Liu MR, Wang H, Deng ZQ, Zhang ZW. Prognostic value of T cell immunoglobulin and mucin-domain containing-3 expression in upper gastrointestinal tract tumors: A meta-analysis. World J Gastrointest Oncol 2023; 15(12): 2212-2224 |
| URL |
https://www.wjgnet.com/1948-5204/full/v15/i12/2212.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v15.i12.2212 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
